[Modification of lipid metabolism by anabolic agents].
D045930:Anabolic Agents / Q000627:therapeutic use*; D002784:Cholesterol / Q000097:blood*; D005032:Ethylestrenol / Q000627:therapeutic use; D005260:Female; D006331:Heart Diseases / Q000188:drug therapy*; D006801:Humans; D008055:Lipids / Q000097:blood*; D008297:Male; D008696:Methandrostenolone / Q000627:therapeutic use; D008777:Methyltestosterone / Q000031:analogs & derivatives / Q000627:therapeutic use; D008875:Middle Aged; D009277:Nandrolone / Q000627:therapeutic use; D010110:Oxymetholone / Q000627:therapeutic use; D010743:Phospholipids / Q000097:blood*; D013739:Testosterone / Q000627:therapeutic use
D045930:Anabolic Agents; D008055:Lipids; D010743:Phospholipids; D013739:Testosterone; D009277:Nandrolone; D002784:Cholesterol; D005032:Ethylestrenol; D008696:Methandrostenolone; D010110:Oxymetholone; D008777:Methyltestosterone
Beeinflussung des Lipidhaushaltes durch anabole Substanzen.